| abstract |
The present invention relates to a compound represented by the following general formula [I], or a pharmaceutically acceptable salt thereof, or a solvate thereof, and a method of using the same as an effective ingredient for rejection of organ transplantation, Diseases, allergic diseases, and medicinal uses for the treatment of chronic myeloproliferative disorders. [Wherein, in the formula, R a is the same or different and represents (1) a C 1-6 alkyl group or the like; n1 represents an integer of 0 to 4; R b are the same or different and represent (1) a C 1-6 alkyl group or the like; n2 represents an integer of 0 to 4; m1 represents an integer of 0 to 3; m2 represents an integer of 1 to 4; X a = X b represents (1) CH = CH and the like; X represents (1) a nitrogen atom or the like; R c represents (1) a hydrogen atom or the like]. |